PURE Bioscience (PURE) Short Interest Ratio & Short Volume → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free PURE Stock Alerts $0.07 0.00 (0.00%) (As of 05/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest PURE Bioscience Short Interest DataCurrent Short Volume2,700 sharesPrevious Short Volume400 sharesChange Vs. Previous Month+575.00%Dollar Volume Sold Short$206.82Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares111,860,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume80 sharesAverage Trading Volume22,637 sharesToday's Volume Vs. Average0% Short Selling PURE Bioscience ? Sign up to receive the latest short interest report for PURE Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPURE Short Interest Over TimePURE Days to Cover Over TimePURE Percentage of Float Shorted Over Time Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit PURE Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,700 shares $206.82 +575.0%N/A0 $0.08 3/31/2024400 shares $39.60 No ChangeN/A0 $0.10 3/15/2024400 shares $36.00 -97.7%N/A0 $0.09 2/29/202417,200 shares $1,886.84 -37.9%N/A1 $0.11 2/15/202427,700 shares $2,963.90 +3,362.5%N/A0.3 $0.11 1/15/20241,700 shares $213.01 +325.0%N/A0 $0.13 Get the Latest News and Ratings for PURE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023400 shares $51.86 -97.2%N/A0 $0.13 12/15/202314,300 shares $2,145.00 +2,760.0%N/A0.1 $0.15 11/30/2023500 shares $59.00 -44.4%N/A0 $0.12 11/15/2023900 shares $92.97 +125.0%N/A0 $0.10 10/31/2023400 shares $32.40 No ChangeN/A0 $0.08 10/15/2023400 shares $47.20 -94.0%N/A0 $0.12 9/30/20236,700 shares $743.70 -10.7%N/A0.1 $0.11 9/15/20237,500 shares $757.50 -61.9%N/A0.1 $0.10 8/31/202319,700 shares $2,068.50 -36.9%N/A0.4 $0.11 8/15/202331,200 shares $3,744.00 +766.7%N/A0.6 $0.12 7/31/20233,600 shares $306.00 -25.0%N/A0.4 $0.09 7/15/20234,800 shares $528.00 +500.0%N/A0.1 $0.11 6/30/2023800 shares $63.92 +100.0%N/A0 $0.08 6/15/2023400 shares $35.85 No ChangeN/A0 $0.09 5/31/2023400 shares $44.40 -93.1%N/A0 $0.11 5/15/20235,800 shares $640.90 -55.0%N/A0.2 $0.11 4/30/202312,900 shares $1,161.00 +101.6%N/A0.1 $0.09 4/15/20236,400 shares $640.00 -14.7%N/A0 $0.10 3/31/20237,500 shares $1,148.06 +368.8%N/A0.1 $0.15 3/15/20231,600 shares $228.32 -90.0%N/A0 $0.14 2/28/202316,000 shares $2,160.00 +3,900.0%N/A0.3 $0.14 2/15/2023400 shares $56.00 -96.2%N/A0 $0.14 1/31/202310,600 shares $1,375.88 +715.4%N/A0.3 $0.13 1/15/20231,300 shares $130.00 +225.0%N/A0 $0.10 12/30/2022400 shares $33.92 -93.8%N/A0 $0.08 12/15/20226,400 shares $851.84 -65.6%N/A0.1 $0.13 11/30/202218,600 shares $2,788.14 +463.6%N/A0.1 $0.15 11/15/20223,300 shares $561.50 -88.5%N/A0.1 $0.17 10/31/202228,600 shares $4,807.66 +5.9%N/A0.3 $0.17 10/15/202227,000 shares $5,211.00 +23.9%N/A1.9 $0.19 9/30/202221,800 shares $4,360.00 +1.4%N/A0.2 $0.20 9/15/202221,500 shares $4,942.85 -40.9%N/A0 $0.23 8/31/202236,400 shares $7,280.00 +23.0%N/A0.2 $0.20 8/15/202229,600 shares $6,808.00 -1.3%N/A0.2 $0.23Missed NVDA? Buy this AI stock NOW (Ad)After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here. PURE Short Interest - Frequently Asked Questions What is PURE Bioscience's current short interest? Short interest is the volume of PURE Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 2,700 shares of PURE short. Learn More on PURE Bioscience's current short interest. Is PURE Bioscience's short interest increasing or decreasing? PURE Bioscience saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,700 shares, an increase of 575.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PURE Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to PURE Bioscience: Psyence Biomedical Ltd. (5.16%), Bionomics Limited (2.03%), Cyclerion Therapeutics, Inc. (1.03%), Pressure BioSciences, Inc. (0.01%), Addex Therapeutics Ltd (2.74%), Vapotherm, Inc. (9.92%), Chemomab Therapeutics Ltd. (1.31%), Medicure Inc. (0.06%), CV Sciences, Inc. (0.04%), Precipio, Inc. (0.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short PURE Bioscience stock? Short selling PURE is an investing strategy that aims to generate trading profit from PURE Bioscience as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PURE Bioscience? A short squeeze for PURE Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PURE, which in turn drives the price of the stock up even further. How often is PURE Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PURE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PBM Short Squeeze BNOX Short Squeeze CYCN Short Squeeze PBIO Short Squeeze ADXN Short Squeeze VAPO Short Squeeze CMMB Short Squeeze MCUJF Short Squeeze CVSI Short Squeeze PRPO Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PURE) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldAI “wealth window” is closing June 25thParadigm PressCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold